These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8867694)

  • 1. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
    Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
    Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas.
    Gottschalk J; Goebel S; Jautzke G; Martin H; Zimmer C; Märzheuser-Brands S; Cervós-Navarro J
    Histol Histopathol; 1992 Oct; 7(4):653-61. PubMed ID: 1360848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence].
    Crafa P; Campanini N; Martella EM; Trabattoni G; Tedeschi F
    Acta Biomed Ateneo Parmense; 1994; 65(5-6):297-308. PubMed ID: 8592922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.
    Demirtaş E; Yilmaz F; Ovül I; Oner K
    Acta Neurochir (Wien); 1996; 138(12):1456-63. PubMed ID: 9030354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas.
    Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G
    Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ag-NOR in meningiomas. Clinical and morphologic study of 14 cases].
    Cerdá-Nicolás M; Pérez-Bacet M; Piquer J; Barcia-Salorio JL
    Arch Neurobiol (Madr); 1992; 55(6):251-5. PubMed ID: 1492778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nucleolar organizer regions in meningiomas with reference to histopathological findings and recurrence].
    Hirayama H; Hara A; Niikawa S; Iwai T; Nishimura Y; Ando T; Sakai N; Yamada H; Takada M
    No To Shinkei; 1993 Apr; 45(4):355-61. PubMed ID: 8334021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar organizer regions in meningiomas. Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome.
    Plate KH; Ruschoff J; Mennel HD
    Anal Quant Cytol Histol; 1990 Dec; 12(6):429-38. PubMed ID: 2078265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolar organizer regions in meningiomas.
    Radhakrishnan VV; Radhakrishnan NS; Rout D; Misna BK
    Br J Neurosurg; 1993; 7(4):377-81. PubMed ID: 8216907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor proliferative fraction in infiltrating duct carcinoma.
    Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The relationship between the prognosis of retinoblastoma and proliferating cell nuclear antigen and argyrophilic protein at nucleolus organizer regions].
    Li D; Song X; Gao Y
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):293-6. PubMed ID: 10451965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive meningiomas in relation to high proliferating potential.
    Suwa T; Kawano N; Kameya T; Ito H; Oka H; Yada K
    Noshuyo Byori; 1993; 10(1):63-7. PubMed ID: 7693228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
    Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
    J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
    Zhao T; Zhang YL; Li CD
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human central nervous tumors].
    Sawada T; Oinuma T; Katada H; Saitoh M; Sakurai I
    Rinsho Byori; 1992 Nov; 40(11):1179-84. PubMed ID: 1284911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
    Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
    Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computerized determination of proliferating cell nuclear antigen expression in meningiomas. A comparison with non-automated method.
    Konstantinidou A; Patsouris E; Kavantzas N; Pavlopoulos PM; Bouropoulou V; Davaris P
    Gen Diagn Pathol; 1997 Jun; 142(5-6):311-6. PubMed ID: 9228254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.